Antithrombotic treatment for peripheral arterial disease
about
Therapeutical potential of direct thrombin inhibitors for atherosclerotic vascular disease.Contemporary platelet function testing.Altered distribution of adrenergic constrictor responses contributes to skeletal muscle perfusion abnormalities in metabolic syndrome.The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle.An exploratory factor analysis of inflammatory and coagulation markers associated with femoral artery atherosclerosis in the San Diego Population Study.
P2860
Antithrombotic treatment for peripheral arterial disease
description
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im März 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: March 2007)
@en
vedecký článok (publikovaný 2007-03)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd in 2007-03)
@nl
наукова стаття, опублікована в березні 2007
@uk
مقالة علمية (نشرت في مارس 2007)
@ar
name
Antithrombotic treatment for peripheral arterial disease
@ast
Antithrombotic treatment for peripheral arterial disease
@en
Antithrombotic treatment for peripheral arterial disease
@nl
type
label
Antithrombotic treatment for peripheral arterial disease
@ast
Antithrombotic treatment for peripheral arterial disease
@en
Antithrombotic treatment for peripheral arterial disease
@nl
prefLabel
Antithrombotic treatment for peripheral arterial disease
@ast
Antithrombotic treatment for peripheral arterial disease
@en
Antithrombotic treatment for peripheral arterial disease
@nl
P2860
P356
P1433
P1476
Antithrombotic treatment for peripheral arterial disease
@en
P2093
Daniel G Hackam
P2860
P356
10.1136/HRT.2006.102350
P407
P577
2007-03-01T00:00:00Z